Patent 7560532 was granted and assigned to Japanese Foundation for Cancer Research on July, 2009 by the United States Patent and Trademark Office.
The invention includes nucleic acids encoding the Smad6 protein, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acids, and antibodies relating thereto. Methods and products for using such nucleic acids and polypeptides also are provided.